| Fluid biomarkers for synaptic dysfunction and loss E Camporesi, J Nilsson, A Brinkmalm, B Becker, NJ Ashton, K Blennow, ... Biomarker insights 15, 1177271920950319, 2020 | 113 | 2020 |
| Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease J Nilsson, J Gobom, S Sjödin, G Brinkmalm, NJ Ashton, J Svensson, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13 (1 …, 2021 | 67 | 2021 |
| Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies L Montoliu-Gaya, AL Benedet, C Tissot, A Vrillon, NJ Ashton, WS Brum, ... Nature Aging 3 (6), 661-669, 2023 | 37 | 2023 |
| Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders J Nilsson, KAQ Cousins, J Gobom, E Portelius, A Chen‐Plotkin, LM Shaw, ... Alzheimer's & Dementia 19 (5), 1775-1784, 2023 | 37 | 2023 |
| Cerebrospinal fluid biomarkers of synaptic dysfunction are altered in Parkinson's disease and related disorders J Nilsson, J Constantinescu, B Nellgård, P Jakobsson, WS Brum, ... Movement Disorders 38 (2), 267-277, 2023 | 25 | 2023 |
| Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia J Gracias, F Orhan, E Hörbeck, J Holmén-Larsson, N Khanlarkani, ... Nature Communications 13 (1), 6427, 2022 | 22 | 2022 |
| Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease J Nilsson, NJ Ashton, AL Benedet, L Montoliu-Gaya, J Gobom, ... Alzheimer's Research & Therapy 14 (1), 78, 2022 | 22 | 2022 |
| Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia A Sogorb-Esteve, J Nilsson, IJ Swift, C Heller, M Bocchetta, LL Russell, ... Alzheimer's research & therapy 14 (1), 118, 2022 | 20 | 2022 |
| Amyloid pathology and synaptic loss in pathological aging E Gkanatsiou, J Nilsson, CE Toomey, A Vrillon, H Kvartsberg, E Portelius, ... Journal of Neurochemistry 159 (2), 258-272, 2021 | 14 | 2021 |
| Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases J Nilsson, A Pichet Binette, S Palmqvist, WS Brum, S Janelidze, ... Brain, awae032, 2024 | 11 | 2024 |
| Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease F Gonzalez-Ortiz, BE Kirsebom, J Contador, JE Tanley, P Selnes, ... Nature Communications 15 (1), 2908, 2024 | 9 | 2024 |
| Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study L Montoliu-Gaya, ML Alosco, E Yhang, Y Tripodis, D Sconzo, M Ally, ... Acta Neuropathologica 147 (1), 5, 2024 | 7 | 2024 |
| Cerebrospinal Fluid Panel of Synaptic Proteins in cerebral amyloid angiopathy and Alzheimer’s Disease E van den Berg, J Nilsson, I Kersten, G Brinkmalm, AM de Kort, CJM Klijn, ... Journal of Alzheimer's Disease 92 (2), 467-475, 2023 | 7 | 2023 |
| Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients BE Kirsebom, G Richter, K Nordengen, D Aarsland, G Bråthen, BM Tijms, ... Brain Communications 4 (5), fcac244, 2022 | 6 | 2022 |
| Combined effects of synaptic and axonal integrity on longitudinal gray matter atrophy in cognitively unimpaired adults R Saloner, C Fonseca, EW Paolillo, BM Asken, NA Djukic, S Lee, ... Neurology 99 (20), e2285-e2293, 2022 | 4 | 2022 |
| Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry E Camporesi, J Nilsson, A Vrillon, E Cognat, C Hourregue, H Zetterberg, ... EBioMedicine 75, 2022 | 4 | 2022 |
| The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease YT Wang, NJ Ashton, S Servaes, J Nilsson, MS Woo, TA Pascoal, C Tissot, ... Translational Neurodegeneration 13 (1), 27, 2024 | 1 | 2024 |
| Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease M Bartl, J Nilsson, M Dakna, S Weber, S Schade, M Xylaki, ... npj Parkinson's Disease 10 (1), 102, 2024 | 1 | 2024 |
| 14-3-3 -reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2 MS Woo, J Nilsson, J Therriault, N Rahmouni, A Brinkmalm, AL Benedet, ... Journal of Neuroinflammation 20 (1), 278, 2023 | 1 | 2023 |
| Cerebrospinal fluid synaptic biomarker changes in bipolar disorder–A longitudinal case-control study U Knorr, AH Simonsen, J Nilsson, A Brinkmalm, H Zetterberg, K Blennow, ... Journal of Affective Disorders 358, 250-259, 2024 | | 2024 |
